Table Info

Table 1.

Clinical characteristics of the total population (n = 64) at baseline and 6 months

Parameters	Baseline	6 months
BMI (kg/m²)	17.50 (15.40, 20.60)	17.90 (15.63, 21.28)
%FVC (L)^*	95.48 ± 9.96	96.00 (90.50, 101.50)
%FEV₁ (L)	98.19 ± 9.71	99.88 ± 9.07
%FEV₁/FVC (L)	103.00 (99.00, 106.50)	102.88 ± 4.72
%PEF(L)	91.00 (80.50, 101.50)	94.50 (87.50, 106.50)
%FEF_25–75% (L)	102.17 ± 19.71	102.67 ± 16.93
7-Item ACQ score	0.29 (0.14, 0.57)	0.14 (0.0, 0.29)
6-Item ACQ score	0.17 (0.00, 0.50)	0.00 (0.00, 0.17)
Asthma control level (%) n, well-controlled	89.10 (57/64)	98.40 (63/64)
Asthma therapy (%) n, yes	82.80 (53/64)	54.70 (35/64)

Data is shown as means ± SD, median (25th, 75th percentiles) or percentages and counts. ^* pre-bronchodilator administration

Supplementary materials

The supplementary material for this article is available at: https://www.explorationpub.com/uploads/Article/file/10093_sup_1.pdf.

Declarations

Acknowledgments

The authors are grateful to Basilopoulos and Sklavenitis supermarkets for their support to economically-disadvantaged families.

Author contributions

MMP: Conceptualization, Visualization, Investigation, Resources, Data curation, Writing—original draft. MMP, KAL, and BE: Formal analysis. BE, CI, and KAL: Supervision, Writing—review & editing. CK and DT equally contributed to: Data curation, Writing—review & editing. All authors read and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This study was approved by La Trobe University Human Ethics Committee (Approval No.: HEC 16-035).

Consent to participate

Informed consent to participate in the study was obtained from all participants.

Consent to publication

Not applicable.

Availability of data and materials

All datasets for this study are included in the manuscript and the supplementary files.

Funding

The first author Maria M. Papamichael was supported by an Australian Post Graduate Award PhD Scholarship (2016–2020) administered by La Trobe University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright

References

Selroos O, Kupczyk M, Kuna P, Łacwik P, Bousquet J, Brennan D, et al. National and regional asthma programmes in Europe. Eur Respir Rev. 2015;24:474–83. Erratum in: Eur Respir Rev. 2019;28:195081. [DOI] [PubMed] [PMC]

Ntzounas A, Giannakopoulos I, Lampropoulos P, Vervenioti A, Koliofoti E, Malliori S. Prevalence of childhood asthma over 40 years in Greece: is the changing trend a result of diagnostic fashion? Authorea [Preprint]. 2021 [cited 2021 Mar 24]. Available from: https://www.authorea.com/users/403877/articles/515204-prevalence-of-childhood-asthma-over-40-years-in-greece-is-the-changing-trend-a-result-of-diagnostic-fashion?commit=d0aac5bd5a592c3d2ff570f423ade31bef9e4818

Chrysaidou K, Kirvassilis F, Karantaglis N, Kontouli K, Hatziagorou E, Tsanakas J. Level of asthma control among asthmatic children in Thessaloniki area in northern Greece. Eur Respir J. 2012;40:P4097.

Global strategy for asthma management and prevention, 2020 [Internet]. Fontana: Global Initiative for Asthma (GINA); c2020 [cited 2020 Apr 3]. Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf

Vellopoulou K, Bakakos P, Loukides S, Maniadakis N, Kourlaba G. The economic burden of asthma in Greece: a cross-sectional study. Appl Health Econ Health Policy. 2019;17:629–40. [DOI] [PubMed]

Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, et al. Global Initiative for Asthma strategy 2021. Respirology. 2022;27:14–35. [DOI] [PubMed]

Lo DKH, Beardsmore CS, Roland D, Richardson M, Yang Y, Danvers L, et al. Lung function and asthma control in school-age children managed in UK primary care: a cohort study. Thorax. 2020;75:101–7. [DOI] [PubMed]

Upton MN, Ferrell C, Bidwell C, McConnachie A, Goodfellow J, Smith GD, et al. Improving the quality of spirometry in an epidemiological study: the Renfrew–Paisley (Midspan) family study. Public Health. 2000;114:353–60. [DOI] [PubMed]

Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14:902–7. [DOI] [PubMed]

10.

Juniper EF, Svensson K, Mörk AC, Ståhl E. Modification of the asthma quality of life questionnaire (standardised) for patients 12 years and older. Health Qual Life Outcomes. 2005;3:58. [DOI] [PubMed] [PMC]

11.

Picado C, Badiola C, Perulero N, Sastre J, Olaguíbel JM, López Viña A, et al.; Covalair Investigator Group. Validation of the Spanish version of the Asthma Control Questionnaire. Clin Ther. 2008;30:1918–31. Erratum in: Clin Ther. 2014;36:1480. [DOI] [PubMed]

12.

Nguyen JM, Holbrook JT, Wei CY, Gerald LB, Teague WG, Wise RA; American Lung Association Asthma Clinical Research Centers. Validation and psychometric properties of the Asthma Control Questionnaire among children. J Allergy Clinical Immunol. 2014;133:91–7.E6. [DOI] [PubMed] [PMC]

13.

Juniper EF, Gruffydd-Jones K, Ward S, Svensson K. Asthma Control Questionnaire in children: validation, measurement properties, interpretation. Eur Respir J. 2010;36:1410–6. [DOI] [PubMed]

14.

Papamichael MM, Katsardis C, Lambert K, Tsoukalas D, Koutsilieris M, Erbas B, et al. Efficacy of a Mediterranean diet supplemented with fatty fish in ameliorating inflammation in paediatric asthma: a randomised controlled trial. J Hum Nutr Diet. 2019;32:185–97. [DOI] [PubMed]

15.

Global strategy for asthma management and prevention, 2016 [Internet]. Fontana: Global Initiative for Asthma (GINA); c2016 [cited 2016 Mar]. Available from: https://ginasthma.org/wp-content/uploads/2019/01/2016-GINA.pdf

16.

Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G^*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149–60. [DOI] [PubMed]

17.

Lee SC, Yang YH, Chuang SY, Huang SY, Pan WH. Reduced medication use and improved pulmonary function with supplements containing vegetable and fruit concentrate, fish oil and probiotics in asthmatic school children: a randomised controlled trial. Brit J Nutr. 2013;110:145–55. [DOI] [PubMed]

18.

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38. [DOI] [PubMed]

19.

Loewenthal K, Lewis CA. An introduction to psychological tests and scales. London: Psychology Press; 2018.

20.

Carroll WD, Wildhaber J, Brand PLP. Parent misperception of control in childhood/adolescent asthma: the Room to Breathe survey. Eur Respir J. 2012;39:90–6. [DOI] [PubMed]

21.

Grammatopoulou E, Stavrou N, Myrianthefs P, Karteroliotis K, Baltopoulos G, Behrakis P, et al. Validity and reliability evidence of the Asthma Control Test – act in Greece. J Asthma. 2010;48:57–64. [DOI] [PubMed]

22.

Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011;2:53–5. [DOI] [PubMed] [PMC]

23.

Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–73. Erratum in: Eur Respir J. 2014;43:1216. Erratum in: Eur Respir J. 2018;52:1352020. Erratum in: Eur Respir J. 2022;59:1362020. [DOI] [PubMed]

24.

Petsios KT, Priftis KN, Tsoumakas C, Perperoglou A, Hatziagorou E, Tsanakas JN, et al. Cough affects quality of life in asthmatic children aged 8-14 more than other asthma symptoms. Allergol Immunopathol (Madr). 2009;37:80–8. [DOI] [PubMed]

25.

Voorend-van Bergen S, Brackel H, Caudri D, de Jongste J, Pijnenburg M. Assessment of asthma control by children and parents. Eur Respir J. 2013;41:233–4. [DOI] [PubMed]